STALICLA is a fast-growing drug development biotech start-up active in the field of autism spectrum disorder (ASD) with offices in Geneva and Barcelona. Through an innovative algorithm-based platform (DEPI) STALICLA has been able to identify non-behavioral subgroups of p...